Virtual 2020 BioHealth Capital Region Forum

Top 3 by 2023

SAVE THE DATE! October 19, 2020


20% of the top influencers worldwide in vaccine development


World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine


MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

BioBuzz: Aurinia Pharmaceuticals Prepares for Commercial Launch from New Maryland Site on the Heels of 2020 Hiring Spree

September 16, 2020

Aurinia Pharmaceuticals (Aurinia) is a late-stage clinical biopharmaceutical company (Toronto Stock Exchange (TSX:AUP); NASDAQ (NASDAQ:AUPH) focused on commercializing therapies for rare autoimmune and inflammatory conditions. Headquartered in Vancouver, British Columbia, the company announced in March…

Prebeo Awarded $150,000 TEDCO MD Innovation Initiative Investment

September 14, 2020

Award to drive development of Prebeo’s technology aimed at reducing the thousands of deaths each year caused by failure to find viable kidney matches for transplantation September 10, 2020, Baltimore,…

GlycoT Therapeutics LLC, a UM Ventures start-up company Signs Sublicense Agreement to Daiichi Sankyo

September 14, 2020

BALTIMORE, Sept. 14, 2020 /PRNewswire/ — GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, Baltimore (UMB) and University of Maryland, College Park (UMCP), has executed a sublicense agreement for its…

BioBuzz – In Conversation with Troy LeMaile-Stovall, TEDCO’s New CEO and Executive Director

September 13, 2020

The Maryland Technology Development Corporation (TEDCO) announced in July 2020 that it had completed the executive search for a new leader with the hiring of Troy LeMaile-Stovall, a seasoned leader with deep ties…

Immunomic Therapeutics Inc. Expands into South Korea

September 10, 2020

Seoul Office Will Be Opening to Develop Immunomic Therapeutics Investigational Cell Therapy for Brain Cancer September 10, 2020 08:00 AM Eastern Daylight Time SEOUL–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held…

Head of JLABS @ Washington, D.C., Sally Allain, MSc., MBA, Guests on BioTalk

September 8, 2020

Sally Allain, MSc., MBA, Head of JLABS @ Washington, D.C. joins Rich Bendis on BioTalk to discuss her career, the decision to open a BioHealth Capital Region location, and their…